Optimization of Stability Indicating RP-HPLC method for The Estimation of an Antidepressant Agents Alprazolam and Imipramine in Pure & Pharmaceutical Dosage Form
 
More details
Hide details
1
Department of Quality Assurance, Sardar Patel College of Pharmacy, India
2
Department of Pharmacology, Sardar Patel College of Pharmacy, India
CORRESPONDING AUTHOR
Payal P. Chauhan   

Department of Quality Assurance, Sardar Patel College of Pharmacy, India
Publish date: 2017-10-27
 
Eurasian J Anal Chem 2016;11(2):101–113
KEYWORDS
ABSTRACT
A Simple, Specific and Precise stability indicating Reverse Phase high performance liquid Chromatography method has been developed and validated for the estimation of Alprazolam and Imipramine in tablet dosage form using ODS-BP Hyperchrome C18 column (250 mm × 4.6 mm id, 5 μm particle size) as a stationary phase, Water (pH -6): Methanol:Triethylamine (70:30:0.1 % v/v/v) as mobile phase, flow rate of 1.0 mL/min and detection was carried out at 216 nm. The retention time of Alprazolam was 3.181 minute and Imipramine was 5.045 minute. RP-HPLC method was developed with linearity range of 0.5 – 1.5 μg/mLAlprazolam and 50 – 150 μg/mL Imipramine. The co-relation coefficient was found to be 0.9999 for Alprazolam and 0.9998 for Imipramine. The assay results obtained in good agreement with the corresponding labeled amount by developed method within range of 99.58% – 101.45% and 98.84% – 99.14% for Alprazolam and Imipramine respectively. Accuracy, Precision, LOD, LOQ, Specificity, Robustness were met all the acceptance criteria for the validation of analytical method as per ICH Q2 (R1) guideline. This method can be conveniently used to detect the possible degradation product in the combined dosage form of Alprazolam and Imipramine during stability studies (acidic, alkaline, oxidative, photolytic and thermal). The method proved to be affective on application to a stressed marketed tablet formulation.
 
REFERENCES (28)
1.
Rang HP, Dale MM, Ritter JM and Flower RJ (2007) Rang & Dale’s Pharmacology, 6th Edition, Churchil Livingstone, London Nature of Depression & Symptom of Depression, p 557-558.
 
2.
Tripathi KD (2008) Essential of Medical Pharmacology, 6thEdition, Jaypee Brothers Medical Publishers Ltd, New Delhi, p 439-449.
 
3.
Ata K, Mohanakrishna A. Majnudar S, Sai R, Ramalingam P (2011), UV spectrophotometric method for the estimation of Alprazolam in tablet dosage form. International Journal of Chemtech Research, 3(1):161-164.
 
4.
Mohammed A, Khan A, Shaista B, Siddiqi K (2013) UV-absorption and fluorimetric methods for the determination of Alprazolam in pharmaceutical formulation. Arabian Journal of Chemistry, 6(4):369–378.
 
5.
Garcı́a E, Montoya A, Orriols M, Minarro JR, Tico JM (2004) Development and validation of a new HPLC analytical method for the determination of Alprazolam in tablets. Pharmaceutical and Biomedical Analysis, 34(59: 979–98.
 
6.
Chaudhary J, Jain A, Saini V (2012) Analytical method development and validation for the simultaneous estimation of Alprazolam and Propranolol in their combined dosage form. International Journal of Drug Delivery, 4: 310-315.
 
7.
Rani GT, Gowrishankar D, Kadgapathi P, Satyanarayana B (2011) A validated RP-HPLC method for simultaneous determination of Propranolol hydrochloride and Alprazolam in bulk and in pharmaceutical formulations. Journal of Pharmacy Research, 4(2): 358-360.
 
8.
Prajapati RR, Dave JB, CN Patel (2011) Development and validation of stability indicating high-performance liquid chromatographic method for simultaneous determination of Alprazolam and Propranolol in combined dosage forms. International Journal of Pharmacy & Technology, 3(2): 2510-2523.
 
9.
Patel RB, Patel MR, Shankar MB and Bhatt KK (2009) Development and validation of second-derivative Spectrophotometry method for simultaneous estimation of Alprazolam and Fluoxetine hydrochloride in pure powder and tablet formulation and its comparison with HPLC method. Eurasian Journal of Analytical Chemistry, 4(1): 76-86.
 
10.
Shukla S, Pankaj K, Moorthya NS, Shrivastav SK, Trivedi P, Srivastav RS (2010) RP-HPLC method development and its validation for simultaneous estimation of Alprazolam and Fluoxetine hydrochloride in pharmaceutical dosage form. Eurasian Journal of Analytical Chemistry, 5(3): 239-245.
 
11.
Patel RB, Patel AB, Patel MR, Shankar MB and Bhatt KK (2009) Estimation of Alprazolam and Sertraline in pure powder and tablet formulations by high-performance liquid chromatography and high-performance thin-layer chromatography. Analytical Letters, 42(11):1588-1602.
 
12.
Venkateswarlu K, Venisetty RK, Keshetty S, Pai MG (2007) Development of HPTLC–UV absorption densitometry method for the analysis of Alprazolam and Sertraline in combination and its application in the evaluation of marketed preparations. Journal of Chromatographic Science, 45: 537-538.
 
13.
Pathak A, Rajput SJ (2008) Development of stability-indicating high-performance liquid chromatographic method for the simultaneous determination of Alprazolam and Sertraline in combined dosage forms. Journal of Association of Official Agricultural Chemists Internationa,l 91(6): 1344-1353.
 
14.
Shah M, Khamar D, Shah N, Makwana A (2012) Development and validation of RP-HPLC and UV spectrophotometric methods for simultaneous estimation of alprazolam and melatonin in combined dosage form. Inventi Rapid - Pharm Analysis & Quality Assurance, 2: 434.
 
15.
Soni P, Sar SK, Kamavisdar A, Patel R (2011) Simple and sensitive spectrophotometric method for determination of tricyclic antidepressant imipramine using Fe(III)-SCN complex. Journal of Analytical Chemistry, 6(66): 596.
 
16.
Susmitha K, Thirumalachary M, Talati V, Venkateshwarlu G (2013) Spectrophotometric determination of Imipramine HCl in pure and pharmaceutical forms. Der Pharma Chemica 5(3): 271-279.
 
17.
Khan UI, Tehseen A, Kazi AA, Azizuddin R (1999) Spectrophotometric determination of Imipramine-HCI in pure and pharmaceutical preparations. Analytical Letters, 32,10: 2061-2069.
 
18.
Wieslawa M, Ewa K & Joanna K (2001) Spectrophotometric determination of Imipramine hydrochloride using ammonium peroxidisulfate and niobium(V) thiocyanate complex. Analytical Letters, 34, 2: 201-209.
 
19.
H. N. Deepakumari, K. B. Vinay and Revanasiddappa H. D (2013) Development and validation of a stability indicating RP-UPLC method for analysis of Imipramine hydrochloride in Pharmaceuticals. ISRN Analytical Chemistry, 2013: 1-10.
 
20.
Gupta SP, Upmanyu N & Garg G (2012) Development and validation of Spectrophotometric, HPTLC and HPLC methods for the determination of Imipramine and Chlordiazepoxide in pharmaceutical dosage forms. Der Pharmacia Sinica, 3(2): 185.
 
21.
Patel S, Patel NJ, and Patel SA (2013) Simultaneous spectrophotometric estimation of Imipramine hydrochloride and Chlordiazepoxide in tablets. Indian Journal of Pharmaceutical Sciences, 71(4): 468–472.
 
22.
Patel AN, Patel AV, Parmar RR, Patel VM, Shah DA (2013) Development and validation of UV spectrophotometric dual wavelength method for simultaneous estimation of Diazepam and Imipramine hydrochloride in pharmaceutical dosage form. Inventi Rapid - Pharm Analysis & Quality Assurance, 13: 1030.
 
23.
Venkata RV & Sharma PK (2013) Analytical method development and validation for simultaneous estimation of Imipramine and Diazepam in tablet dosage form by RP-HPLC. International Journal of Pharmacy and Pharmaceutical Sciences 5: 249 - 253.
 
24.
Pydiratnam P, Santosh Kumar T, Satyanarayana S (2013) Development and validation of stability indicating RP-HPLC method for simultaneous estimation of Imipramine hydrochloride and Diazepam in pharmaceutical dosage form. International Journal of Pharmaceutics and Drug Analysis, 1(1): 13 – 24.
 
25.
Patel AN, Patel AV, Patel BR, Parmar RR, Shah DA (2013) Development and validation of UV spectrophotometric HPTLC for simultaneous estimation of Diazepam and Imipramine hydrochloride in pharmaceutical dosage form. Inventi Rapid - Pharm Analysis & Quality Assurance, 13: 1054.
 
26.
International Conference on Harmonization Guideline on Validation of Analytical Procedures (2005) Text and Methodology: Q2 (R1).
 
27.
FDA Guidance for Industry (2008) Analytical Procedures and Methods Validation - Chemistry, Manufacturing, and Controls Documentation.
 
28.
Chen C (2008) Pharmaceutical Manufacturing Handbook: Regulations and Quality, John Wiley & Sons, p 728-729.
 
eISSN:1306-3057